ATE168006T1 - Neue medizinische anwendung eines gewissen indolderivates und dieses enthaltende pharmazeutische zubereitung - Google Patents

Neue medizinische anwendung eines gewissen indolderivates und dieses enthaltende pharmazeutische zubereitung

Info

Publication number
ATE168006T1
ATE168006T1 AT91917473T AT91917473T ATE168006T1 AT E168006 T1 ATE168006 T1 AT E168006T1 AT 91917473 T AT91917473 T AT 91917473T AT 91917473 T AT91917473 T AT 91917473T AT E168006 T1 ATE168006 T1 AT E168006T1
Authority
AT
Austria
Prior art keywords
medical use
new medical
pharmaceutical preparation
pct
preparation containing
Prior art date
Application number
AT91917473T
Other languages
English (en)
Inventor
Alison Jane Pilgrim
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE168006T1 publication Critical patent/ATE168006T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Neurosurgery (AREA)
  • Indole Compounds (AREA)
AT91917473T 1990-10-12 1991-10-11 Neue medizinische anwendung eines gewissen indolderivates und dieses enthaltende pharmazeutische zubereitung ATE168006T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909022250A GB9022250D0 (en) 1990-10-12 1990-10-12 Medicaments

Publications (1)

Publication Number Publication Date
ATE168006T1 true ATE168006T1 (de) 1998-07-15

Family

ID=10683660

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91917473T ATE168006T1 (de) 1990-10-12 1991-10-11 Neue medizinische anwendung eines gewissen indolderivates und dieses enthaltende pharmazeutische zubereitung

Country Status (16)

Country Link
US (1) US5376672A (de)
EP (1) EP0552205B1 (de)
JP (1) JP3159263B2 (de)
KR (1) KR0178762B1 (de)
AT (1) ATE168006T1 (de)
AU (1) AU660153B2 (de)
CA (1) CA2093527A1 (de)
DE (1) DE69129750T2 (de)
DK (1) DK0552205T3 (de)
ES (1) ES2118090T3 (de)
GB (1) GB9022250D0 (de)
IE (1) IE913580A1 (de)
IL (1) IL99715A (de)
TW (1) TW212756B (de)
WO (1) WO1992006688A1 (de)
ZA (1) ZA918117B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69435270D1 (de) * 1993-12-28 2010-04-01 Allergan Inc Verwendung der neurotoxischen Komponente von Botulinum Toxin zur Behandlung spastischer Muskeln
RU2180852C2 (ru) * 1994-12-12 2002-03-27 Омерос Медикл Системс, Инк. Ингибирующий раствор и способ подавления боли, воспаления или спазма
US20040068000A1 (en) * 2002-10-02 2004-04-08 Mintong Guo Compression coated tablets
US20080213363A1 (en) * 2003-01-23 2008-09-04 Singh Nikhilesh N Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
CA2569964A1 (en) * 2004-06-10 2005-12-29 Duramed Pharmaceuticals, Inc. Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
EP2124556B1 (de) 2006-10-09 2014-09-03 Charleston Laboratories, Inc. Pharmazeutische zusammensetzungen
EP2240022B1 (de) 2008-01-09 2016-12-28 Charleston Laboratories, Inc. Oxycodone und Promethazine enthaltende zweischichtige Tabletten
US8304179B2 (en) * 2009-05-11 2012-11-06 Taiwan Semiconductor Manufacturing Company, Ltd. Method for manufacturing a semiconductor device using a modified photosensitive layer
US20100287502A1 (en) * 2009-05-11 2010-11-11 Olympus Imaging Corp. Image search device and image search method
EP3311667A1 (de) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmazeutische zusammensetzungen
CA3055170A1 (en) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Pharmaceutical compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
GB8332437D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative

Also Published As

Publication number Publication date
IL99715A (en) 1996-01-19
CA2093527A1 (en) 1992-04-13
EP0552205A1 (de) 1993-07-28
IE913580A1 (en) 1992-04-22
DE69129750T2 (de) 1998-11-12
US5376672A (en) 1994-12-27
ZA918117B (en) 1992-08-26
KR0178762B1 (ko) 1999-03-20
ES2118090T3 (es) 1998-09-16
GB9022250D0 (en) 1990-11-28
IL99715A0 (en) 1992-08-18
JP3159263B2 (ja) 2001-04-23
DK0552205T3 (da) 1999-04-19
AU660153B2 (en) 1995-06-15
EP0552205B1 (de) 1998-07-08
AU8642291A (en) 1992-05-20
JPH06501935A (ja) 1994-03-03
TW212756B (de) 1993-09-11
WO1992006688A1 (en) 1992-04-30
DE69129750D1 (de) 1998-08-13

Similar Documents

Publication Publication Date Title
TR199902253T2 (xx) �n g�z odac���nda farmas�tik maddelerin kontroll� sal�n�m�.
ATE231719T1 (de) Neue pharmazeutische formulierungen
ATE168006T1 (de) Neue medizinische anwendung eines gewissen indolderivates und dieses enthaltende pharmazeutische zubereitung
IT1202558B (it) Protesi interna per la sostituzione di una parte del corpo umano particolarmente nelle operazioni vascolari
CO4340681A1 (es) Procedimientos de uso para la inhibicion de la perdida osea y la disminucion del colesterol en suero
BR9508655A (pt) Composição farmacêutica aquosa estéril
ID28003A (id) Turunan-turunan adamantana
IT1274879B (it) Apparecchio e metodo per preparare forme farmaceutiche solide a rilascio controllato del principio attivo.
DE69721766D1 (de) Neue arzneiformulierung
DE69400435D1 (de) Verwendung von carbamazepine und oxcarbazepine zur behandlung von parkinson und den parkinson-syndromen
DE69226649D1 (de) Analoge des menschlichen Interleukin-8.
ATE213633T1 (de) Lamotrigin haltiges arzneimittel
HUT76796A (en) Use of 2,4-diamino pyrimidine 3-oxide or salts thereof for preparing pharmaceutical composition for treating collagen maturation and structruring disorders
FI970434A (fi) Uudet 3-substituoidut 3H-2,3-bentsodiatsepiinijohdannaiset, niiden valmistus ja käyttö lääkkeenä
SE9502219D0 (sv) Novel medical use
ATE155683T1 (de) Arzneimittel zur verhinderung der toleranzentwicklung während der behandlung mit benzodiazepin-rezeptor-bindenden wirkstoffen
NO950177L (no) Farmakologisk aktive erivater
SE9604752D0 (sv) Formulation and use
DE69616591D1 (de) Pharmazeutische zusammensetzung, die muirapuama und pflanzenwürmer enthaelt
NO952912D0 (no) En ny osteoblastisk proliferativ faktor
ES2054325T3 (es) Nuevos estereoisomeros.
SE9500897D0 (sv) The pharmacological use of certain cystine derivatives
FI960026A (fi) Värejä, joissa on tetra-aminopyrimidiiniä ja suoravärjäysaineita
GEP19981392B (en) N,n-dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-yl- methyl)-1h-indol-3-yl) ethylamine, indole derivatives and physiologically acceptable salts and solvates thereof, methods of preparing thereof, drug for treatment or prophylaxes of clinical states for which administration of 5-ht1-like receptor agonist, and method of preparing thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee